Phytoestrogens, cancer and coronary heart disease.
Recent results obtained in collaboration with many other groups with regard to phytoestrogens (isoflavones and lignans) and breast cancer, prostate cancer and cardiovascular disease are presented and discussed in light of new developments in the field. Both isoflavones and lignans may be protective with regard to these diseases, but we do not yet understand some of the controversial results obtained. In this short communication the possible mechanisms of disease prevention were not discussed.
Adlercreutz
Herman
H
Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center, and Division of Clinical Chemistry, Biomedicum, POB 63, 00014 University of Helsinki, Finland. herman.adlercreutz@helsinki.fi
Heinonen
Satu-Maarit
SM
Penalvo-Garcia
José
J
D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002523:Edible Grain; D005638:Fruit; D006801:Humans; D008297:Male; D048789:Phytoestrogens / Q000494:pharmacology*; D011471:Prostatic Neoplasms / Q000517:prevention & control; D014675:Vegetables
D016588:Anticarcinogenic Agents; D002316:Cardiotonic Agents; D048789:Phytoestrogens